Use of tranexamic acid in per trochanteric fractures: Is it beneficial?

Abstract

Background: Elderly people who have hip fractures frequently need blood transfusions. The purpose of this study was to ascertain whether tranexamic acid (TXA) usage in hip fracture patients lowers intraoperative and postoperative blood loss. For a year, patients with hip fractures were the subjects of the study. Two groups of patients were formed, with one getting TXA and the other receiving a placebo (1:1). Both the amount of drainage during the 48-hour postoperative period and the amount of blood lost during the procedure were measured. Patients who received TXA experienced a 1.4 fold reduction in total blood loss (368.61 vs.529.24 mL of blood). Thus the use of TXA in patients with per trochanteric fractures significantly reduces intraoperative and postoperative blood loss.